These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 30821295

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Impact of the main implantable cardioverter-defibrillator trials for primary and secondary prevention in Italy: a survey of the national activity during the years 2001-2004.
    Proclemer A, Ghidina M, Cicuttini G, Gregori D, Fioretti PM.
    Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S20-8. PubMed ID: 17169129
    [Abstract] [Full Text] [Related]

  • 23. The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not?
    Botto GL, Forleo GB, Capucci A, Solimene F, Vado A, Bertero G, Palmisano P, Pisanò E, Rapacciuolo A, Infusino T, Vicentini A, Viscusi M, Ferrari P, Talarico A, Russo G, Boriani G, Padeletti L, Lovecchio M, Valsecchi S, D'Onofrio A, ‘AIAC S-ICD Why Not’ Survey Investigators.
    Europace; 2017 Nov 01; 19(11):1826-1832. PubMed ID: 28011803
    [Abstract] [Full Text] [Related]

  • 24. Appropriateness of implantable cardioverter-defibrillator device implants in the United States.
    Yousuf OK, Kennedy K, Russo A, Varosy P, Lindsay BD, Steinberg B, Atwater BD, Calkins H, Spertus JA.
    Heart Rhythm; 2024 Apr 01; 21(4):397-407. PubMed ID: 38123044
    [Abstract] [Full Text] [Related]

  • 25. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A, Kutarski A, Czekajska-Chehab E, Adamczyk P, Boczar K, Polewczyk M, Janion M.
    Cardiol J; 2014 Apr 01; 21(2):128-37. PubMed ID: 24526508
    [Abstract] [Full Text] [Related]

  • 26. Seventeen-year trend (2001-2017) in pacemaker and implantable cardioverter-defibrillator utilization based on hospital discharge database data: An analysis by age groups.
    Zecchin M, Torre M, Carrani E, Sampaolo L, Ciminello E, Ortis B, Ricci R, Proclemer A, Sinagra G, Boriani G.
    Eur J Intern Med; 2021 Feb 01; 84():38-45. PubMed ID: 32933841
    [Abstract] [Full Text] [Related]

  • 27. Favorable Trend of Implantable Cardioverter-Defibrillator Service Life in a Large Single-Nation Population: Insights From 10-Year Analysis of the Italian Implantable Cardioverter-Defibrillator Registry.
    Poli S, Boriani G, Zecchin M, Facchin D, Gasparini M, Landolina M, Ricci RP, Lanera C, Gregori D, Proclemer A.
    J Am Heart Assoc; 2019 Aug 06; 8(15):e012759. PubMed ID: 31340695
    [Abstract] [Full Text] [Related]

  • 28. [Spanish registry of implantable cardioverter defibrillator. Second official report of the Spanish Society of Cardiology Working Group on Implantable Cardioverter Defibrillators (2005)].
    Peinado R, Torrecilla EG, Ormaetxe J, Alvarez M, Spanish Society of Cardiology Working Group on Implantable Cardioverter Defibrillators.
    Rev Esp Cardiol; 2006 Dec 06; 59(12):1292-302. PubMed ID: 17194425
    [Abstract] [Full Text] [Related]

  • 29. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
    Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, Sharma A, Dual Chamber and VVI Implantable Defibrillator Trial Investigators.
    JAMA; 2002 Dec 25; 288(24):3115-23. PubMed ID: 12495391
    [Abstract] [Full Text] [Related]

  • 30. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL, Dual Chamber and VVI Implantable Defibrillator trial investigators.
    Card Electrophysiol Rev; 2003 Dec 25; 7(4):468-72. PubMed ID: 15071277
    [Abstract] [Full Text] [Related]

  • 31. Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis.
    Narducci ML, Biffi M, Ammendola E, Vado A, Campana A, Potenza DR, Iori M, Zanon F, Zacà V, Zoni Berisso M, Bertini M, Lissoni F, Bandini A, Malacrida M, Crea F.
    Europace; 2018 Sep 01; 20(9):1475-1483. PubMed ID: 29186401
    [Abstract] [Full Text] [Related]

  • 32. Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
    Marzec LN, Peterson PN, Bao H, Curtis JP, Masoudi FA, Varosy PD, Bradley SM.
    JAMA Cardiol; 2017 May 01; 2(5):561-565. PubMed ID: 28122073
    [Abstract] [Full Text] [Related]

  • 33. The Australian and New Zealand cardiac pacing and implantable cardioverter-defibrillator survey: calendar year 2005.
    Mond HG, Whitlock RM.
    Heart Lung Circ; 2008 Apr 01; 17(2):85-9. PubMed ID: 17822954
    [Abstract] [Full Text] [Related]

  • 34. Age-Stratified Clinical Outcome in Patients with Known Heart Failure Who Receive Pacemaker, Resynchronization Therapy, or Defibrillator Implants.
    Rorsman C, Farouq M, Marinko S, Platonov PG, Borgquist R.
    Cardiology; 2024 Apr 01; 149(5):474-483. PubMed ID: 38555639
    [Abstract] [Full Text] [Related]

  • 35. Frequency of Need for Antitachycardia or Antibradycardia Pacing or Cardiac Resynchronization Therapy in Patients With a Single-Chamber Implantable Cardioverter-Defibrillator.
    Melles MC, Yap SC, Bhagwandien RE, Sakhi R, Szili-Torok T, Theuns DAMJ.
    Am J Cardiol; 2018 Dec 15; 122(12):2068-2074. PubMed ID: 30340766
    [Abstract] [Full Text] [Related]

  • 36. Trends in Use of Single- vs Dual-Chamber Implantable Cardioverter-Defibrillators Among Patients Without a Pacing Indication, 2010-2018.
    Borne RT, Varosy P, Lan Z, Masoudi FA, Curtis JP, Matlock DD, Peterson PN.
    JAMA Netw Open; 2022 Mar 01; 5(3):e223429. PubMed ID: 35315917
    [Abstract] [Full Text] [Related]

  • 37. The Australian and New Zealand cardiac pacing and implantable cardioverter-defibrillator survey: calendar year 1997.
    Mond HG, Whitlock RM.
    Intern Med J; 2001 Jul 01; 31(5):267-71. PubMed ID: 11512597
    [Abstract] [Full Text] [Related]

  • 38. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
    Ip JE, Wu MS, Kennel PJ, Thomas G, Liu CF, Cheung JW, Markowitz SM, Lerman BB.
    J Cardiovasc Electrophysiol; 2017 May 01; 28(5):544-548. PubMed ID: 28185354
    [Abstract] [Full Text] [Related]

  • 39. Spanish Pacemaker Registry. Twelfth Official Report of the Spanish Society of Cardiology Working Group on Cardiac Pacing (2014).
    Cano Pérez Ó, Pombo Jiménez M, Coma Samartín R.
    Rev Esp Cardiol (Engl Ed); 2015 Dec 01; 68(12):1138-53. PubMed ID: 26553269
    [Abstract] [Full Text] [Related]

  • 40. Candidacy for a Subcutaneous Implantable Cardioverter Defibrillator in Patients with Cardiac Resynchronization Therapy.
    Kawabata M, Goya M, Takahashi Y, Maeda S, Yagishita A, Shirai Y, Kaneko M, Shiohira S, Hirao K.
    Int Heart J; 2018 Sep 26; 59(5):951-958. PubMed ID: 30101850
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.